Endothelial PERK restricts lymphoid regeneration by reducing DLL4-NOTCH3 signaling at the Pre-B niche. [PDF]
Zou B +17 more
europepmc +1 more source
We recently noted that low doses of sorafenib and vorinostat interact in a synergistic fashion to kill carcinoma cells by activating CD95, and this drug combination is entering phase I trials.
Grant, S +14 more
core
QRICH1 Suppresses Glioma Progression by Inducing ER Stress and Activating the PERK-ATF4-CHOP Pathway. [PDF]
Wang Y +7 more
europepmc +1 more source
STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. [PDF]
Kepp O, Kroemer G.
europepmc +1 more source
Translational dysregulation as a mechanistic driver of cognitive, behavioral, and affective phenotypes in FXS and TSC. [PDF]
Lawal S, Mujtaba M, Shrestha P.
europepmc +1 more source
HGSNAT alleviates oxygen-glucose deprivation- induced endothelial injury by suppressing ER stress: implications for Moyamoya disease. [PDF]
Wen Z +6 more
europepmc +1 more source
KRAS-driven protein disulfide isomerase family A member 6 expression suppresses PRKR-like endoplasmic reticulum kinase-mediated immunogenic cell death to desensitise pancreatic ductal adenocarcinoma to immune checkpoint blockers. [PDF]
Wang R +18 more
europepmc +1 more source
The integrated stress response in pancreatic β-cell failure in diabetes: from molecular mechanisms to precision therapeutics. [PDF]
Huang Y, Zeng Y, Zhong X, Li L.
europepmc +1 more source
Mitochondria-Endoplasmic Reticulum Crosstalk in Pancreatic β-Cell Stress: A Driver of Diabetes. [PDF]
Niinuma SA +4 more
europepmc +1 more source

